Compass Therapeutics (CMPX) Other Operating Expenses (2021 - 2022)
Compass Therapeutics (CMPX) posted Other Operating Expenses of $69000.0 for Q2 2022, up 56.82% sequentially from $44000.0 in Q1 2021.
Compass Therapeutics (CMPX) Other Operating Expenses (2021 - 2022) Analysis & Trends
Compass Therapeutics has reported Other Operating Expenses for 2 years, with the latest figure at $69000.0 in Q2 2022.
- Quarterly Other Operating Expenses changed N/A year-over-year to $69000.0 in Q2 2022, while the trailing twelve-month figure through Mar 2023 was $69000.0 (changed N/A YoY) and the FY2021 annual result came in at $50.6 million, up 18113.52% from the prior year.
- Other Operating Expenses rose to $69000.0 in Q2 2022 per CMPX's latest filing, from $44000.0 in the prior quarter.
- Over five years, Other Operating Expenses peaked at $69000.0 in Q2 2022 and troughed at $44000.0 in Q1 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Compass Therapeutics | 405.20 Mn | 405.20 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2022 | 69,000.00 |
| Mar 31, 2021 | 44,000.00 |